Author

Vicki Thallas‐Bonke

Observed names: V. Thallas-Bonke, Vicki Thallas-Bonke, Vicki Thallas-bonke

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Albert Einstein College of Medicine, Royal Children's Hospital, Baker Heart and Diabetes Institute, The University of Queensland, The University of Melbourne, University of Southern Denmark, Heidelberg University, Austin Hospital, Juvenile Diabetes Research Foundation, Murdoch Children's Research Institute, Monash University

OpenAlex ID: A5072552257

RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes

2009 · Melinda T. Coughlan, David R. Thorburn, et al. · Journal of the American Society of Nephrology · 472

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

2014 · Jay C. Jha, Stephen P. Gray, et al. · Journal of the American Society of Nephrology · 352

PDF

Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway

2007 · Vicki Thallas-Bonke, Suzanne R. Thorpe, et al. · Diabetes · 345

PDF

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

2007 · Paul Lewis, Nada Stefanovic, et al. · Circulation · 246

PDF

Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition

2006 · Wendy C. Burns, Stephen M. Twigg, et al. · Journal of the American Society of Nephrology · 243

Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy

2005 · Josephine M. Forbes, Suzanne R. Thorpe, et al. · Journal of the American Society of Nephrology · 210

Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes

2016 · Melinda T. Coughlan, Tuong-Vi Nguyen, et al. · Clinical Science · 170

Processed foods drive intestinal barrier permeability and microvascular diseases

2021 · Matthew Snelson, Sih Min Tan, et al. · Science Advances · 154

PDF

Attenuation of Extracellular Matrix Accumulation in Diabetic Nephropathy by the Advanced Glycation End Product Cross-Link Breaker ALT-711 via a Protein Kinase C-α−Dependent Pathway

2004 · Vicki Thallas-Bonke, Carsten Lindschau, et al. · Diabetes · 152

Advanced Glycation End Products Are Direct Modulators of β-Cell Function

2011 · Melinda T. Coughlan, Felicia Y.T. Yap, et al. · Diabetes · 149

PDF

NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy

2017 · Jay C. Jha, Claudine Banal, et al. · Diabetes · 142

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy

2015 · Jay C. Jha, Vicki Thallas-Bonke, et al. · Diabetologia · 142

PDF

Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy

2009 · Adeline L. Y. Tan, Karly C. Sourris, et al. · American Journal of Physiology-Renal Physiology · 124

Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?

2006 · Melinda T. Coughlan, Vicki Thallas-Bonke, et al. · Endocrinology · 124

Targeted reduction of advanced glycation improves renal function in obesity

2011 · Brooke E. Harcourt, Karly C. Sourris, et al. · Kidney International · 122

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β

2011 · Michal Herman-Edelstein, Merlin C. Thomas, et al. · Diabetes · 116

PDF

Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy

2014 · Vicki Thallas-Bonke, Jay C. Jha, et al. · Physiological Reports · 100

PDF

Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility

2019 · Sih Min Tan, Mark Ziemann, et al. · Diabetes · 94

PDF

AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy

2015 · Christine Koulis, Bryna S.M. Chow, et al. · Hypertension · 67

A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products

2006 · M. A. Zimanyi, K. M. Denton, et al. · Diabetologia · 65

PDF

Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis

2016 · Melinda T. Coughlan, Gavin C. Higgins, et al. · Diabetes · 57

PDF

Nox-4 and progressive kidney disease

2014 · Vicki Thallas-Bonke, Karin A.M. Jandeleit-Dahm, et al. · Current Opinion in Nephrology & Hypertension · 46

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

2014 · Kei Fukami, Sho-ichi Yamagishi, et al. · Diabetology & Metabolic Syndrome · 39

PDF

Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D

2020 · Runa S.J. Lindblom, Gavin C. Higgins, et al. · Clinical Science · 35

PDF

Targeting the AGE‐RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end‐product content

2012 · Vicki Thallas‐Bonke, Melinda T Coughlan, et al. · Nephrology · 32

Works count: 48

Citation count: 3,882

H-index: 25

I10-index: 29